HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Biologic drugs, also known as biologics or biological therapies, have emerged as a ground breaking category of treatments in the field of cancer. These drugs are designed using living organisms, cells, or components of cells to target specific molecules involved in cancer growth and progression. Unlike traditional chemotherapy, which often affects both cancer and healthy cells, biologics offer a more targeted approach, minimizing damage to normal tissues.
Monoclonal antibodies, a type of biologic drug, are engineered to recognize and bind to specific proteins on the surface of cancer cells. This targeted binding can stimulate the immune system to attack and destroy cancer cells. Additionally, some biologics work by blocking signals that promote cancer growth, inhibiting the formation of new blood vessels that tumors need for nourishment, or enhancing the body's ability to recognize and eliminate cancer cells. Biologic drugs have shown remarkable success in treating various cancers, including breast cancer, colorectal cancer, and certain types of leukemia and lymphoma. As research in immunotherapy and biologics advances, the development of new and innovative biologic drugs continues to shape the landscape of cancer treatment, offering patients more effective and tailored therapeutic options.
